Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by Polar Capital Holdings Plc

Polar Capital Holdings Plc lowered its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 9.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 349,761 shares of the company’s stock after selling 34,818 shares during the period. Polar Capital Holdings Plc owned 0.38% of Acadia Healthcare worth $13,868,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Wellington Management Group LLP grew its position in shares of Acadia Healthcare by 0.7% in the fourth quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company’s stock valued at $465,283,000 after purchasing an additional 76,490 shares during the period. FMR LLC boosted its position in Acadia Healthcare by 257.9% during the fourth quarter. FMR LLC now owns 6,230,631 shares of the company’s stock worth $247,045,000 after acquiring an additional 4,489,681 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Acadia Healthcare by 18.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company’s stock worth $126,189,000 after acquiring an additional 486,395 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after purchasing an additional 454,044 shares during the period. Finally, Madison Avenue Partners LP purchased a new position in Acadia Healthcare during the fourth quarter worth about $76,339,000.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Bank of America reduced their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. Mizuho reduced their target price on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a research note on Wednesday. Royal Bank of Canada reduced their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research note on Monday, March 3rd. Barclays reduced their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Finally, KeyCorp reduced their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating on the stock in a research note on Wednesday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Acadia Healthcare currently has an average rating of “Moderate Buy” and an average target price of $47.94.

Acadia Healthcare Price Performance

Shares of ACHC opened at $25.64 on Friday. Acadia Healthcare Company, Inc. has a fifty-two week low of $20.36 and a fifty-two week high of $82.41. The firm’s 50 day moving average price is $26.25 and its 200 day moving average price is $35.83. The company has a market cap of $2.36 billion, a P/E ratio of 8.41, a PEG ratio of 1.46 and a beta of 1.01. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. During the same period in the prior year, the firm earned $0.84 EPS. The firm’s revenue for the quarter was up .3% on a year-over-year basis. On average, research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.